Related stories
Eos Energy Enterprises Reports Third-Quarter Loss per Share
M impact | EQUITY | Nov 05, 2026, 11:51 AM UTC
Latigo Biotherapeutics Reports Third-Quarter 2026 Results and Business Highlights
The company said Phase 3 bunionectomy and open-label safety trials of onzotrigine remain on track for initiation; the source text is truncated.
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
Protean eGov Technologies Reports Q2 Revenue of INR 2,707.8 Million
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
BeOne Medicines Q3 Net Profit Up 304.3% Y/Y
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
Arhaus Q3 Earnings Fall as Revenue Rises; 2026 Guidance Lifted
Arhaus reported Q3 earnings of $0.05 per share and lifted its 2026 revenue guidance.
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC
Cascades Reports Q3 Adjusted Earnings of CA$0.33, Down YoY
Cascades booked Q3 adjusted earnings of CA$0.33, lower year over year.
M impact | EQUITY | Nov 05, 2026, 11:47 AM UTC